Baker Avenue Asset Management, LP Cue Biopharma, Inc. Transaction History

Baker Avenue Asset Management, LP

  • $3.41 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$1.24 - $2.18 $75,568 - $132,853
60,942 Added 188.22%
93,320 $115,000
Q2 2023

Aug 11, 2023
BUY
$3.11 - $4.91 $95,253 - $150,383
30,628 Added 1750.17%
32,378 $118,000
Q4 2022

Feb 13, 2023
BUY
$2.39 - $3.95 $4,182 - $6,912
1,750 New
1,750 $4,000

Others Institutions Holding CUE

# of Institutions
52
Shares Held
14.1M
Call Options Held
14.4K
Put Options Held
2.6K
View Full List

About Cue Biopharma, Inc.

CUE Quotes by TradingView
  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $38.2M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email